17 Results

People

  1. Shah
    Shah
  2. Lesokhin
    Lesokhin
  3. Mailankody
    Mailankody
  4. Hassoun
    Hassoun
  5. Korde
    Korde
  6. Hultcrantz
    Hultcrantz
  7. Tan
    Tan
  8. Usmani
    Usmani
  9. Derkach
    Derkach
  10. Giralt
    Giralt

Groups

  1. CTCR Scholars (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Center for Hematologic Malignancies (14)
  5. Hematologic Malignancies Research (14)
  6. Myeloma (14)
  7. Survivorship Research (11)
  8. Sloan Kettering Institute Postdocs (9)
  9. Biostatistics Service (8)
  10. Bone Marrow Transplant (8)
  1. "female"
  2. "Urvi Shah"
Formats
  1. Journal Article (10)
  2. Research Letter (5)
  3. Correspondence (2)
Groups
  1. CTCR Scholars (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Center for Hematologic Malignancies (14)
  5. Hematologic Malignancies Research (14)
  6. Myeloma (14)

More Groups

People
  1. Urvi Shah (17)
  2. Alexander Lesokhin (14)
  3. Sham Mailankody (12)
  4. Hani Hassoun (10)
  5. Malin Hultcrantz (9)
  6. Neha Korde (9)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (4)
  6. 2019 (1)
Publications
  1. Blood Advances (2)
  2. Blood Cancer Journal (2)
  3. Leukemia (2)
  4. Leukemia and Lymphoma (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Blood (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Society of Hematology (3)
  3. Elsevier Inc. (2)
  4. Taylor & Francis Group (2)
  5. American Medical Association (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study
    Research Letter

    Castro, F.; Parikh, R.; Eustaquio, J. C.; Derkach, A.; Joseph, J. M.; Lesokhin, A. M.; Usmani, S. Z.; Shah, U. A.
    Leukemia (2024)

    Fulltext@MSK | Save
  • Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population
    Journal Article

    Joseph, J. M.; Hillengass, J.; Tang, L.; Lesokhin, A. M.; Landgren, O.; Usmani, S. Z.; Moysich, K. B.; McCann, S. E.; Shah, U. A.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
    Journal Article

    Van Oekelen, O.; Nath, K.; Mouhieddine, T. H.; Farzana, T.; Aleman, A.; Melnekoff, D. T.; Ghodke-Puranik, Y.; Shah, G. L.; Lesokhin, A.; Giralt, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Extreme body mass index and survival in newly diagnosed multiple myeloma patients
    Correspondence

    Shah, U. A.; Whiting, K.; Devlin, S.; Ershler, R.; Kanapuru, B.; Lee, D. J.; Tahri, S.; Gwise, T.; Rustad, E. H.; Mailankody, S.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Research Letter

    Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
    Research Letter

    Shah, U. A.; Rögnvaldsson, S.; Derkach, A.; Björkholm, M.; Turesson, I.; David, Y.; Hultcrantz, M.; Tan, C.; Hassoun, H.; Korde, N.; more...
    Haematologica (2022)

    Fulltext@MSK | Save